Lars Østergaard - Concepedia

Author

Lars Østergaard

Also Known As

Bodil C Arp, C Pedersen, C. Pedersen, Christina Bergsoe, D Chadwick, David da Silva Té, Henrik Nielsen, I S Johansen, I. S. Johansen, Ines Oliviera-Souto

465

Publications

17.9K

Citations

H-Index

183

Concepts

All Affiliations

Aarhus University Hospital Aarhus University Aalborg University Hospital University of Southern Denmark Rigshospitalet

LØ

About

Lars Østergaard is an author at Aarhus University Hospital specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	58	6.2K
2	Education	2	2	85
3	Engineering	2	2	77
4	Health Sciences	2	2	85
5	Natural Sciences	1	1	332

Lars Østergaard

212

Publications

14.5K

Citations

H-Index

Page 1

	Year	Citations
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten, The Lancet Oncology Surgical OncologyRadiation TherapyGastrointestinal OncologyMedicineColorectal Cancer	2020	1.5K
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study Alison Rodger, Valentina Cambiano, Tina Bruun, The Lancet	2019	966
Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders Hjördís Ósk Atladóttir, Poul Thorsen, Lars Østergaard, Journal of Autism and Developmental Disorders Maternal ImmunizationAutism Spectrum DisordersMaternal ComplicationGynecologyMaternal Health	2010	917
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial Thomas A. Rasmussen, Martin Tolstrup, Christel R. Brinkmann, The Lancet HIV Histone Deacetylase InhibitorTreatment And PreventionNeurovirologyMedicineImmunology	2014	629
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo Ole S. Søgaard, Mette E. Graversen, Steffen Leth, PLoS Pathogens	2015	514
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication Martin R. Jakobsen, Rasmus O. Bak, Annika Andersen, Proceedings of the National Academy of Sciences Lentiviral Replication CycleViral ReplicationImmunologyImmune RegulationMolecular Biology	2013	332
Functional IRF3 deficiency in a patient with herpes simplex encephalitis Line Lykke Andersen, Nanna Mørk, Line S. Reinert, The Journal of Experimental Medicine Autoimmune DiseaseNeurovirologyPathogenesisImmunologyViral Pathogenesis	2015	222
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. Jesper Damsgaard Gunst, Marie H. Pahus, Lena Hagelskjær Kristensen, EClinicalMedicine Controlled TrialCovid-19 PandemicClinical TrialsAntiviral TherapyCovid-19-a Double-blind	2021	192
Comparison of HDAC inhibitors in clinical development Thomas A. Rasmussen, Ole S. Søgaard, Christel R. Brinkmann, Human Vaccines & Immunotherapeutics	2013	189
DC-SIGN (CD209), pentraxin 3 and vitamin D receptor gene variants associate with pulmonary tuberculosis risk in West Africans Rikke Olesen, Christian Wejse, Digna R. Velez, Genes and Immunity Disease SusceptibilityPulmonary TuberculosisPulmonary Tuberculosis RiskTuberculosis PreventionGenetic Epidemiology	2007	185

Page 1